Rhabdomyolysis associated with the use of a mislabeled "acai Berry" dietary supplement

American Journal of the Medical Sciences

Volumn 342, Issue 6, 2011, Pages 535-538

  Elsayed, Raghda K ^a   Glisson, James K ^b   Minor, Deborah S ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Acai berry; Amlodipine; Dietary supplement; Rhabdomyolysis; Weight loss

Indexed keywords

AMLODIPINE; CAFFEINE; CREATINE KINASE; CREATININE; MYOGLOBIN; SODIUM CHLORIDE;

ACAI BERRY; ADULT; ARTICLE; BERRY; CASE REPORT; CONSERVATIVE TREATMENT; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; EMERGENCY WARD; FATIGUE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MUSCLE DISEASE; MYALGIA; ORAL REHYDRATION THERAPY; RHABDOMYOLYSIS; SYMPTOM; URINE COMPOSITION DISORDER; URINE VOLUME; WEIGHT REDUCTION;

EID: 82355185875     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822c0933     Document Type: Article

References (25)

1. Radimer K, Bindewald B, Hughes J, et al. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004;160:339-49. (Pubitemid 39045265)
2. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008;10:1-23.
3. Food and Drug Administration. FDA issues dietary supplements final rule. 2007. Available at: www.fda.gov/NewsEvents/Newsroom/Press Announcements/2007/ ucm108938.htm. Accessed March 23, 2010.
4. Acai berry select weight loss formula: ingredients. 2009. Available at: www.acaiberryselect.com. Accessed August 24, 2009.
5. Natural standard: the authority on integrative medicine. Acai berry monograph online. Available at: www.naturalstandard.com. Accessed March 23, 2010.
6. Cullum-Dugan D, Saper RD. Obesity. In: Rakel D, editor, Integrative medicine, 2nd ed. Philadelphia (PA): Saunders Elsevier; 2007, Chapter 39. Available at: www.mdconsult.com.ezproxy.library.umc.edu. Accessed March 23, 2010.
7. The United States Pharmacopeia. The USP Dietary Supplement Verification Program. Available at: www.usp.org/USPVerified/dietary Supplements/. Accessed June 1, 2010.
8. De Brito ES, De Araújo MC, Alves RE, et al. Anthocyanins present in selected tropical fruits: acerola, jambolao, jussara, and guajiru. J Agric Food Chem 2007;55:9389-94. (Pubitemid 350205287)
9. Reich E, Schibli A, Widmer V, et al. HPTLC methods for identification of green tea and green tea extract. J Liq Chromatogr Related Technol 2006;29:2141-51. (Pubitemid 44091879)
10. Hagan RL. High-performance liquid chromatography for small-scale studies of drug stability. Am J Hosp Pharm 1994;51:2162-75. (Pubitemid 24279990)
11. Schaneberg BT, Khan IA. Quantitative and qualitative HPLC analysis of thermogenic weight loss products. Pharmazie 2004;59:819-23. (Pubitemid 39524575)
12. O'Connor FG, Deuster PA. Rhabdomyolysis. In: Goldman L, Aus-iello D, editors. Cecil textbook of medicine, 23rd ed. Philadelphia (PA): Saunders Elsevier; 2008, Chapter 114. Available at: www.mdconsult. com.ezproxy.library. umc.edu. Accessed September 6, 2009.
13. Chan SS, Li S, Lin G. Pitfalls of the selection of chemical markers for the quality control of medicinal herbs. J Food Drug Anal 2007;15:365-71. (Pubitemid 351385209)
14. Mansi IA, Huang J. Rhabdomyolysis in response to weight-loss herbal medicine. Am J Med Sci 2004;327:356-7. (Pubitemid 38780182)
15. Kamijo Y, Soma K, Asari Y, et al. Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia. Vet Hum Toxicol 1999;41:381-3.
16. Wrenn KD, Oschner I. Rhabdomyolysis induced by a caffeine overdose. Ann Emerg Med 1989;18:94-7. (Pubitemid 19037223)
17. Curry SC, Chang D, Connor D. Drug-and toxin-induced rhabdomy-olysis. Ann Emerg Med 1989;18:1068-84.
18. Bryan J. Psychological effects of dietary components of tea: caffeine and L-theanine. Nutr Rev 2008;66:82-90. (Pubitemid 351666653)
19. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhab-domyolysis. Pharmacotherapy 1998;18:860-2.
20. Gagliano M, Corona D, Giuffrida G, et al. Low-intensity body building exercise induced rhabdomyolysis: a case report. Cases J 2009;2:7.
21. Pfizer. Norvasc (amlodipine) package insert. New York (NY): Pfizer; 2006.
22. Bjornsson TD, Callaghan JT, Einolf HJ, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. J Clin Pharmacol 2003;43:443-69. (Pubitemid 36506147)
23. Nakagawa K, Nakayama K, Nakamura M, et al. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans. Biosci Biotechnol Biochem 2009;73:2014-7.
24. Phillips BB, Muller BA. Severe neuromuscular complications possibly associated with amlodipine. Ann Pharmacother 1998;32:1165-7. (Pubitemid 28543462)
25. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30: 239-45. (Pubitemid 12149145)